Bacil Pharma Ltd.
BSE: 524516 | Sector: Health care |
NSE: N.A. | ISIN Code: INE711D01018 |
BSE 00:00 | 26 May | 5.10 |
0.24 (4.94%) |
OPEN
4.62 |
HIGH
5.10 |
LOW
4.62 |
NSE 05:30 | 01 Jan | Bacil Pharma Ltd |
OPEN | 4.62 |
PREVIOUS CLOSE | 4.86 |
VOLUME | 1530 |
52-Week high | 9.55 |
52-Week low | 3.67 |
P/E | |
Mkt Cap.(Rs cr) | 3 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Bacil Pharma Ltd. (BACILPHARMA) - Competition
COMPANY | Last Price | Market Cap. (Rs. cr.) |
Sales Turnover | Net Profit | Total Assets |
Sun Pharma.Inds. | 900.55 | 216,068.95 | 12,803.21 | 2,139.70 | 32,510.54 |
Divi's Lab. | 3,449.15 | 91,557.69 | 6,798.61 | 1,954.72 | 9,297.17 |
Cipla | 964.40 | 77,807.79 | 13,900.58 | 2,468.28 | 20,166.89 |
Dr Reddy's Labs | 4,307.25 | 71,681.25 | 13,349.10 | 2,186.40 | 18,266.10 |
Apollo Hospitals | 3,668.00 | 52,738.50 | 9,153.00 | 105.00 | 8,226.00 |
Torrent Pharma. | 2,900.90 | 49,089.03 | 6,450.83 | 1,137.85 | 10,618.60 |
Gland Pharma | 2,853.25 | 46,964.49 | 3,462.88 | 997.01 | 5,909.86 |
Piramal Enterp. | 1,855.90 | 44,291.05 | 1,824.70 | 39.90 | 29,983.67 |
Biocon | 325.35 | 39,061.52 | 2,028.40 | 280.50 | 8,024.20 |
Zydus Lifesci. | 372.85 | 38,168.66 | 7,790.40 | 1,476.20 | 16,841.70 |
Abbott India | 17,698.85 | 37,610.06 | 4,310.02 | 690.69 | 2,844.49 |
Alkem Lab | 3,024.35 | 36,156.10 | 7,219.68 | 1,685.08 | 9,195.63 |
Max Healthcare | 367.50 | 35,633.90 | 1,079.68 | -164.45 | 6,439.88 |
Aurobindo Pharma | 535.50 | 31,374.95 | 15,823.68 | 3,112.91 | 19,952.13 |
Laurus Labs | 559.20 | 30,048.61 | 4,768.72 | 956.11 | 4,255.44 |
Lupin | 600.75 | 27,304.09 | 11,055.93 | 1,258.62 | 19,354.36 |
Glaxosmi. Pharma | 1,513.25 | 25,635.97 | 3,193.74 | 357.57 | 1,798.50 |
Ipca Labs. | 917.15 | 23,268.10 | 5,139.16 | 1,140.77 | 5,028.39 |
Syngene Intl. | 527.40 | 21,171.42 | 2,179.40 | 403.70 | 4,022.40 |
Pfizer | 4,247.95 | 19,434.37 | 2,238.55 | 497.61 | 2,494.06 |
Quick Links for Bacil Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices